Amphastar Pharmaceuticals
AMPH
AMPH
146 hedge funds and large institutions have $549M invested in Amphastar Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 53 increasing their positions, 44 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.34% more ownership
Funds ownership: 54.89% → 57.23% (+2.3%)
Holders
146
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$11.2M | |
| 2 | +$4.91M | |
| 3 | +$3.74M | |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$3.73M |
| 5 |
JPMorgan Chase & Co
New York
|
+$2.76M |
Top Sellers
| 1 | -$2.93M | |
| 2 | -$2.34M | |
| 3 | -$2.17M | |
| 4 |
Millennium Management
New York
|
-$2.08M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$2.01M |